Literature DB >> 21239611

Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase.

Shoichiro Kokabu1, Satoshi Ohte, Hiroki Sasanuma, Masashi Shin, Katsumi Yoneyama, Eiko Murata, Kazuhiro Kanomata, Junya Nojima, Yusuke Ono, Tetsuya Yoda, Toru Fukuda, Takenobu Katagiri.   

Abstract

Bone morphogenetic proteins (BMPs) induce osteoblastic differentiation in myogenic cells via the phosphorylation of Smads. Two types of Smad phosphatases--small C-terminal domain phosphatase 1 (SCP1) and protein phosphatase magnesium-dependent 1A--have been shown to inhibit BMP activity. Here, we report that SCP1 inhibits the osteoblastic differentiation induced by BMP-4, a constitutively active BMP receptor, and a constitutively active form of Smad1. The phosphatase activity of SCP1 was required for this suppression, and the knockdown of SCP1 in myoblasts stimulated the osteoblastic differentiation induced by BMP signaling. In contrast to protein phosphatase magnesium-dependent 1A, SCP1 did not reduce the protein levels of Smad1 and failed to suppress expression of the Id1, Id2, and Id3 genes. Runx2-induced osteoblastic differentiation was suppressed by SCP1 without affecting the transcriptional activity or phosphorylation levels of Runx2. Taken together, these findings suggest that SCP1 may inhibit the osteoblastic differentiation induced by the BMP-Smad axis via Runx2 by suppressing downstream effector(s).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239611      PMCID: PMC5417272          DOI: 10.1210/me.2010-0305

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  34 in total

1.  PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.

Authors:  Xia Lin; Xueyan Duan; Yao-Yun Liang; Ying Su; Katharine H Wrighton; Jianyin Long; Min Hu; Candi M Davis; Jinrong Wang; F Charles Brunicardi; Yigong Shi; Ye-Guang Chen; Anming Meng; Xin-Hua Feng
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

2.  Small CTD phosphatases function in silencing neuronal gene expression.

Authors:  Michele Yeo; Soo-Kyung Lee; Bora Lee; Esmeralda C Ruiz; Samuel L Pfaff; Gordon N Gill
Journal:  Science       Date:  2005-01-28       Impact factor: 47.728

3.  Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway.

Authors:  Xueyan Duan; Yao-Yun Liang; Xin-Hua Feng; Xia Lin
Journal:  J Biol Chem       Date:  2006-08-24       Impact factor: 5.157

4.  Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal.

Authors:  Luis C Fuentealba; Edward Eivers; Atsushi Ikeda; Cecilia Hurtado; Hiroki Kuroda; Edgar M Pera; Edward M De Robertis
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

5.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

6.  Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells.

Authors:  A Hollnagel; V Oehlmann; J Heymer; U Rüther; A Nordheim
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

7.  Bone: formation by autoinduction.

Authors:  M R Urist
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

8.  Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.

Authors:  Takenobu Katagiri; Mana Imada; Takeshi Yanai; Tatsuo Suda; Naoyuki Takahashi; Ryutaro Kamijo
Journal:  Genes Cells       Date:  2002-09       Impact factor: 1.891

9.  Bone morphogenetic protein-2 does not alter the differentiation pathway of committed progenitors of osteoblasts and chondroblasts.

Authors:  M Komaki; T Katagiri; T Suda
Journal:  Cell Tissue Res       Date:  1996-04       Impact factor: 5.249

10.  Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles.

Authors:  Yusuke Ono; Luisa Boldrin; Paul Knopp; Jennifer E Morgan; Peter S Zammit
Journal:  Dev Biol       Date:  2009-10-14       Impact factor: 3.582

View more
  11 in total

1.  BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b.

Authors:  Shoichiro Kokabu; Laura Gamer; Karen Cox; Jonathan Lowery; Kunikazu Tsuji; Regina Raz; Aris Economides; Takenobu Katagiri; Vicki Rosen
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.

Authors:  Yael Aschner; Anthony P Khalifah; Natalie Briones; Cory Yamashita; Lior Dolgonos; Scott K Young; Megan N Campbell; David W H Riches; Elizabeth F Redente; William J Janssen; Peter M Henson; Jan Sap; Nathalie Vacaresse; Andras Kapus; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

3.  The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor.

Authors:  Shoichiro Kokabu; Chihiro Nakatomi; Takuma Matsubara; Yusuke Ono; William N Addison; Jonathan W Lowery; Mariko Urata; Aaron M Hudnall; Suzuro Hitomi; Mitsushiro Nakatomi; Tsuyoshi Sato; Kenji Osawa; Tetsuya Yoda; Vicki Rosen; Eijiro Jimi
Journal:  J Biol Chem       Date:  2017-06-12       Impact factor: 5.157

4.  Two-track virtual screening approach to identify both competitive and allosteric inhibitors of human small C-terminal domain phosphatase 1.

Authors:  Hwangseo Park; Hye Seon Lee; Bonsu Ku; Sang-Rae Lee; Seung Jun Kim
Journal:  J Comput Aided Mol Des       Date:  2017-06-26       Impact factor: 3.686

5.  Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylation.

Authors:  Rayana L Bighetti-Trevisan; Luciana O Almeida; Larissa M S Castro-Raucci; Jonathan A R Gordon; Coralee E Tye; Gary S Stein; Jane B Lian; Janet L Stein; Adalberto L Rosa; Marcio M Beloti
Journal:  Biomater Adv       Date:  2021-11-13

6.  Geranylgeraniol-induced Myogenic Differentiation of C2C12 Cells.

Authors:  Takuma Matsubara; Mariko Urata; Tsuyoshi Nakajima; Mari Fukuzaki; Ryo Masuda; Yoshiyuki Yoshimoto; William N Addison; Chihiro Nakatomi; Kazmasa Morikawa; Min Zhang; Katsura Saeki; Yukiko Takahashi; Atsuko Nakamichi; Shoichiro Kokabu
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

7.  Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.

Authors:  Paul D Upton; Rachel J Davies; Tamara Tajsic; Nicholas W Morrell
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

Review 8.  Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy.

Authors:  SongTing Shi; David J J de Gorter; Willem M H Hoogaars; Peter A C 't Hoen; Peter ten Dijke
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

9.  Unveiling novel genes upregulated by both rhBMP2 and rhBMP7 during early osteoblastic transdifferentiation of C2C12 cells.

Authors:  Juan C Bustos-Valenzuela; Andre Fujita; Erik Halcsik; Jose M Granjeiro; Mari C Sogayar
Journal:  BMC Res Notes       Date:  2011-09-26

Review 10.  The diverse roles of RNA polymerase II C-terminal domain phosphatase SCP1.

Authors:  Harikrishna Reddy R; Hackyoung Kim; Kwangmo Noh; Young Jun Kim
Journal:  BMB Rep       Date:  2014-04       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.